82 research outputs found

    Comparing a Modified Dry By-product to Dry Distillers Grains with Solubles in Growing Calf Diets

    Get PDF
    A growing trial was conducted to contrast a new by-product, Dakota Bran Cake (DBRAN), against dry distillers grains with solubles (DDGS) and evaluate the two by-products at two dietary inclusion levels on steer calf performance measurements. Diet treatments included 15% DBRAN, 30% DBRAN, 15% DDGS, and 30% DDGS, replacing a blend (70:30 ratio) of brome grass hay and alfalfa haylage (DM basis). Final BW, ADG, and DMI increased, while F:G decreased as the inclusion level for both of these by-products increased from 15 to 30% DM. DDGS significantly improved ADG and F:G compared to feeding DBRAN at both inclusion levels. Feeding DBRAN and DDGS in growing diets to steer calves improved performance at higher dietary inclusion levels, while DDGS tended to improve performance over DBRAN

    Evaluation of Dry Distillers Grains Plus Solubles Inclusion on Performance and Economics of Finishing Beef Steers

    Get PDF
    A 167-d feedlot study was conducted to evaluate feeding increasing levels of dry distillers grains plus solubles (DDGS) to finishing cattle and the impact on performance and profitability. Crossbred steer calves (n = 240, BW = 306 ± 24.5 kg) were used in 30 pens with dietary treatments of 0, 10, 20, 30, and 40% DDGS dietary inclusion (DM basis). Quadratic relationships (P \u3c 0.05) were observed for final BW and ADG as dietary DDGS increased, with the greatest ADG observed at 20% inclusion. The DMI was not affected (P \u3e 0.15) by DDGS level, but G:F tended to be quadratic (P = 0.10) as 20% DM inclusion had the greatest value, although steers fed all levels of DDGS had numerically greater G:F compared with steers fed no DDGS. Carcass characteristics, other than hot carcass weight, were not affected by DDGS treatment. Energy value of DDGS at 10 to 40% dietary inclusion resulted in a quadratic trend (P = 0.10) and remained above corn, with the highest values at 10 and 20% inclusion averaging 127% of corn. When DDGS was priced equally to corn, all levels of DDGS from 10 to 40% inclusion resulted in higher profits compared with a dry-rolled corn based diet regardless of corn price. The greatest returns were observed when cattle were fed 20% DDGS. These data indicate that DDGS can be fed up to 40% DM to improve cattle performance and result in economic profits, with optimum levels at 20 to 30% diet DM

    Evaluation of Dry Distillers Grains Plus Solubles Inclusion on Performance and Economics of Finishing Beef Steers

    Get PDF
    A 167-d feedlot study was conducted to evaluate feeding increasing levels of dry distillers grains plus solubles (DDGS) to finishing cattle and the impact on performance and profitability. Crossbred steer calves (n = 240, BW = 306 ± 24.5 kg) were used in 30 pens with dietary treatments of 0, 10, 20, 30, and 40% DDGS dietary inclusion (DM basis). Quadratic relationships (P \u3c 0.05) were observed for final BW and ADG as dietary DDGS increased, with the greatest ADG observed at 20% inclusion. The DMI was not affected (P \u3e 0.15) by DDGS level, but G:F tended to be quadratic (P = 0.10) as 20% DM inclusion had the greatest value, although steers fed all levels of DDGS had numerically greater G:F compared with steers fed no DDGS. Carcass characteristics, other than hot carcass weight, were not affected by DDGS treatment. Energy value of DDGS at 10 to 40% dietary inclusion resulted in a quadratic trend (P = 0.10) and remained above corn, with the highest values at 10 and 20% inclusion averaging 127% of corn. When DDGS was priced equally to corn, all levels of DDGS from 10 to 40% inclusion resulted in higher profits compared with a dry-rolled corn based diet regardless of corn price. The greatest returns were observed when cattle were fed 20% DDGS. These data indicate that DDGS can be fed up to 40% DM to improve cattle performance and result in economic profits, with optimum levels at 20 to 30% diet DM

    Effect of Bio-Oss® Collagen and Collagen Matrix on Bone Formation

    Get PDF
    Objective: to compare the amount of new bone produced by Bio-Oss ® Collagen to that produced by collagen matrix in vivo. Method: eighteen bone defects, 5mm by 10mm were created in the parietal bone of 9 New Zealand White rabbits. 6 defects were grafted with Bio-Oss ® Collagen. 6 defects were grafted with collagen matrix alone (positive control) and 6 were left empty (negative control). Animals were killed on day 14 and the defects were dissected and prepared for histological assessment. Quantitative analysis of new bone formation was made on 100 sections (50 sections for each group) using image analysis. Results: A total of 339% more new bone was present in defects grafted with Bio-Oss ® Collagen than those grafted with collagen matrix (positive control). No bone was formed in the negative control group. Conclusion: Bio-Oss ® Collagen has the effect of stimulating new bone formation locally compared with collagen matrix in vivo. Bio-Oss ® Collagen may be utilized as a bone graft material. © Wong and Rabie; Licensee Bentham Open.published_or_final_versio

    Increased DNA methylation variability in type 1 diabetes across three immune effector cell types

    Get PDF
    The incidence of type 1 diabetes (T1D) has substantially increased over the past decade, suggesting a role for non-genetic factors such as epigenetic mechanisms in disease development. Here we present an epigenome-wide association study across 406,365 CpGs in 52 monozygotic twin pairs discordant for T1D in three immune effector cell types. We observe a substantial enrichment of differentially variable CpG positions (DVPs) in T1D twins when compared with their healthy co-twins and when compared with healthy, unrelated individuals. These T1D-associated DVPs are found to be temporally stable and enriched at gene regulatory elements. Integration with cell type-specific gene regulatory circuits highlight pathways involved in immune cell metabolism and the cell cycle, including mTOR signalling. Evidence from cord blood of newborns who progress to overt T1D suggests that the DVPs likely emerge after birth. Our findings, based on 772 methylomes, implicate epigenetic changes that could contribute to disease pathogenesis in T1D.This work was funded by the EU-FP7 project BLUEPRINT (282510) and the Wellcome Trust (99148). We thank all twins for taking part in this study; Kerra Pearce and Mark Kristiansen (UCL Genomics) for processing the Illumina Infinium HumanMethylation450 BeadChips; Rasmus Bennet for technical assistance; and Laura Phipps for proofreading the manuscript. The BMBF Pediatric Diabetes Biobank recruits patients from the National Diabetes Patient Documentation System (DPV), and is financed by the German Ministry of Education and Research within the German Competence Net Diabetes Mellitus (01GI1106 and 01GI1109B). It was integrated into the German Center for Diabetes Research in January 2015. We thank the Swedish Research Council and SUS Funds for support. We gratefully acknowledge the participation of all NIHR Cambridge BioResource volunteers, and thank the Cambridge BioResource staff for their help with volunteer recruitment. We thank members of the Cambridge BioResource SAB and Management Committee for their support of our study and the NIHR Cambridge Biomedical Research Centre for funding. The Cardiovascular Epidemiology Unit is supported by the UK Medical Research Council (G0800270), BHF (SP/09/002), and NIHR Cambridge Biomedical Research Centre. Research in the Ouwehand laboratory is supported by the NIHR, BHF (PG-0310-1002 and RG/09/12/28096) and NHS Blood and Transplant. K.D. is funded as a HSST trainee by NHS Health Education England. M.F. is supported by the BHF Cambridge Centre of Excellence (RE/13/6/30180). A.D., E.L., L.C. and P.F. receive additional support from the European Molecular Biology Laboratory. A.K.S. is supported by an ADA Career Development Award (1-14-CD-17). B.O.B. and R.D.L. acknowledge support from the Deutsche Forschungsgemeinschaft (DFG) and European Federation for the Study of Diabetes, respectively

    Congenital Hypogonadotropic Hypogonadism Due to GNRH Receptor Mutations in Three Brothers Reveal Sites Affecting Conformation and Coupling

    Get PDF
    Congenital hypogonadotropic hypogonadism (CHH) is characterized by low gonadotropins and failure to progress normally through puberty. Mutations in the gene encoding the GnRH receptor (GNRHR1) result in CHH when present as compound heterozygous or homozygous inactivating mutations. This study identifies and characterizes the properties of two novel GNRHR1 mutations in a family in which three brothers display normosmic CHH while their sister was unaffected. Molecular analysis in the proband and the affected brothers revealed two novel non-synonymous missense GNRHR1 mutations, present in a compound heterozygous state, whereas their unaffected parents possessed only one inactivating mutation, demonstrating the autosomal recessive transmission in this kindred and excluding X-linked inheritance equivocally suggested by the initial pedigree analysis. The first mutation at c.845 C>G introduces an Arg substitution for the conserved Pro 282 in transmembrane domain (TMD) 6. The Pro282Arg mutant is unable to bind radiolabeled GnRH analogue. As this conserved residue is important in receptor conformation, it is likely that the mutation perturbs the binding pocket and affects trafficking to the cell surface. The second mutation at c.968 A>G introduces a Cys substitution for Tyr 323 in the functionally crucial N/DPxxY motif in TMD 7. The Tyr323Cys mutant has an increased GnRH binding affinity but reduced receptor expression at the plasma membrane and impaired G protein-coupling. Inositol phosphate accumulation assays demonstrated absent and impaired Gαq/11 signal transduction by Pro282Arg and Tyr323Cys mutants, respectively. Pretreatment with the membrane permeant GnRHR antagonist NBI-42902, which rescues cell surface expression of many GNRHR1 mutants, significantly increased the levels of radioligand binding and intracellular signaling of the Tyr323Cys mutant but not Pro282Arg. Immunocytochemistry confirmed that both mutants are present on the cell membrane albeit at low levels. Together these molecular deficiencies of the two novel GNRHR1 mutations lead to the CHH phenotype when present as a compound heterozygote

    AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases

    Get PDF
    Previous studies showed an association of the common functional polymorphism (C34T, Gln12Stop) in the adenosine monophosphate deaminase-1 (AMPD1) gene with survival in heart failure (HF) and/or coronary artery disease (CAD). The aim of the study was to search for other mutations in selected regions of the AMPD1 gene in Polish CAD and HF patients, and to analyze their associations with obesity and diabetes. Exons 2, 3, 5, and 7 of AMPD1 were scanned for mutations in 97 patients with CAD without HF (CAD+ HF−), 104 patients with HF (HF+), and 200 newborns from North-Western Poland using denaturing high-performance liquid chromatography (DHPLC), polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP), and direct sequencing. Frequencies of AMPD1 C34T mutation, as well as novel A99G, G512A, IVS4-6delT, and C784T sequence alterations, were similar in the three groups, but 860T mutated allele was less frequent in the combined CAD+ HF− and HF+ groups than in the controls (1.7% vs. 4.3%, p = 0.040). Heterozygous 34CT genotype was associated with lower (odds ratio [OR] = 0.32, 95% confidence interval [CI] = 0.13–0.81) and 860AT with higher (OR = 13.7, 95%CI = 1.6–118) prevalence of diabetes or hyperglycemia in relation to wild-type homozygotes. Abdominal obesity was more frequent in 860AT patients than in wild-type homozygotes and 34CT heterozygotes (86% vs. 40% vs. 29%, p < 0.05). Nine genes containing polymorphisms linked with AMPD1 C34T mutation were found in the HapMap database. AMPD1 C34T nonsense mutation is associated with reduced prevalence of diabetes and obesity in patients with CAD or HF, but A860T substitution seems to exert opposite metabolic effects and should always be accounted for in the studies of the AMPD1 genotype

    Case report: maternal mosaicism resulting in inheritance of a novel GATA6 mutation causing pancreatic agenesis and neonatal diabetes mellitus.

    Get PDF
    Haploinsufficiency of the GATA6 transcription factor gene was recently found to be the most common cause of pancreatic agenesis, a rare cause of neonatal diabetes mellitus. Although most cases are de novo, we describe three siblings with inherited GATA6 haploinsufficiency and the rare finding of parental mosaicism.This article is freely available via Open Access. Click on the Additional Link above to access the full-text via the publisher's site

    Позиционный электропривод механизма перемещения

    Get PDF
    Объектом исследования является позиционный асинхронный электропривод механизма горизонтального перемещения груза. Цель работы – исследовать основные характеристики асинхронного электропривода с трехконтурной системой управления положением вала двигателя. В процессе исследования проводились выбор асинхронного двигателя для механизма перемещения, расчет параметров двигателя, его статических и динамических характеристик, выбор преобразователя частоты, синтез трехконтурной системы управления следящим электроприводом на базе регулируемого с векторным управлением.The object of the study is a positional asynchronous electric drive mechanism for the horizontal movement of cargo. The purpose of the work is to investigate the basic characteristics of an asynchronous electric drive with a three-circuit control system for positioning the motor shaft. In the process of research, the choice of an asynchronous motor for the displacement mechanism, calculation of the engine parameters, its static and dynamic characteristics, choice of a frequency converter, synthesis of a three-circuit control system for a servomotor drive based on an adjustable vector control were made
    corecore